KR Choksey's research report on Fineotex Chemicals
For Q3FY24, Fineotex Chemicals’(FCL) posted a revenue of INR 1385 Mn growing by 26% YoY and -5% QoQ on a consolidated basis. For 9MFY24 revenue stood at INR 4160 Mn, growing by 10%. Volumes grew by 37% Y-o-Y. EBITDA stood at INR 404 Mn, on the back of 42% gross margins, with EBITDA margin coming in at 29%. with margin expansion of 301 bps. EBITDA for 9MFY24 was INR 1101 Mn growing by 38%. PAT for the quarter came in at INR 329 MN, with margins at 24%, expanding by 320 bps YoY, for 9MFY24 PAT was INR 905 MN growing by 42%. On a standalone basis FCL grew its PAT by ~100%. EPS for the quarter came in at INR 2.95/share, compared with INR 2 in the same quarter last year. For 9MFY24, the EPS stood at INR 8.10, comparing with INR 5.64 a growth of 43%. The Board of Directors have approved a dividend of 1.20/share, a payout ratio of 15% for 9MFY24.
Outlook
Currently, the stock is trading at 41x/31x/23x FY24E/FY25E/FY26E EPS, respectively. We increase our FY26E EPS estimate to INR 19.03 (previously INR 17.7) and assign a PE multiple of 30x to arrive at a target price of INR 570 (previously INR 531). Given the 29% upside from current levels, we retain our “BUY” rating on Fineotex Chemicals Ltd.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.